NICOTINE IN ANGIOGENESIS AND THERAPEUTIC VASCULOGENESIS.

摘要

Use of a nicotine receptor agonist for the manufacture of a medicament for the treatment or prevention of a disease involving angiogenesis selected from myocardial infarction, coronary occlusive disease, carotid occlusive disease, arterial occlusive disease, peripheral arterial disease, arteriosclerosis , myointimal hyperplasia, thromboangiitis obliterans, thrombotic disorders, vasculitis, mesenteric or limbic ischemia, vascular occlusion, and stenosis.